Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
Saved in:
| Title: | Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. |
|---|---|
| Authors: | Deanfield J; Institute of Cardiovascular Sciences, University College London, London, UK. Electronic address: john.e.deanfield@gmail.com., Verma S; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON, Canada., Scirica BM; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kahn SE; Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA., Emerson SS; Department of Biostatistics, University of Washington, Seattle, WA, USA., Ryan D; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Lingvay I; Department of Internal Medicine/Endocrinology and Peter O'Donnell Jr School of Public Health, UT Southwestern Medical Center, Dallas, TX, USA., Colhoun HM; Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Plutzky J; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kosiborod MN; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA., Hovingh GK; Novo Nordisk, Søborg, Denmark; Department of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, Netherlands., Hardt-Lindberg S; Novo Nordisk, Søborg, Denmark., Frenkel O; Novo Nordisk, Søborg, Denmark., Weeke PE; Novo Nordisk, Søborg, Denmark., Rasmussen S; Novo Nordisk, Søborg, Denmark., Goudev A; Department of Cardiology, Queen Giovanna University Hospital, Sofia, Bulgaria., Lang CC; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK., Urina-Triana M; Faculty of Health Sciences, Universidad Simón Bolívar, Barranquilla, Colombia., Pietilä M; Heart Center, Turku University Hospital, University of Turku, Turku, Finland., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA. |
| Corporate Authors: | SELECT Trial Investigators |
| Source: | Lancet (London, England) [Lancet] 2024 Aug 24; Vol. 404 (10454), pp. 773-786. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39181597 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Deanfield+J%22">Deanfield J</searchLink>; Institute of Cardiovascular Sciences, University College London, London, UK. Electronic address: john.e.deanfield@gmail.com.<br /><searchLink fieldCode="AU" term="%22Verma+S%22">Verma S</searchLink>; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Scirica+BM%22">Scirica BM</searchLink>; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kahn+SE%22">Kahn SE</searchLink>; Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Emerson+SS%22">Emerson SS</searchLink>; Department of Biostatistics, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Ryan+D%22">Ryan D</searchLink>; Pennington Biomedical Research Center, Baton Rouge, LA, USA.<br /><searchLink fieldCode="AU" term="%22Lingvay+I%22">Lingvay I</searchLink>; Department of Internal Medicine/Endocrinology and Peter O'Donnell Jr School of Public Health, UT Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Colhoun+HM%22">Colhoun HM</searchLink>; Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Plutzky+J%22">Plutzky J</searchLink>; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kosiborod+MN%22">Kosiborod MN</searchLink>; Department of Cardiovascular Disease, Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.<br /><searchLink fieldCode="AU" term="%22Hovingh+GK%22">Hovingh GK</searchLink>; Novo Nordisk, Søborg, Denmark; Department of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Hardt-Lindberg+S%22">Hardt-Lindberg S</searchLink>; Novo Nordisk, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Frenkel+O%22">Frenkel O</searchLink>; Novo Nordisk, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Weeke+PE%22">Weeke PE</searchLink>; Novo Nordisk, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Rasmussen+S%22">Rasmussen S</searchLink>; Novo Nordisk, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Goudev+A%22">Goudev A</searchLink>; Department of Cardiology, Queen Giovanna University Hospital, Sofia, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Lang+CC%22">Lang CC</searchLink>; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK.<br /><searchLink fieldCode="AU" term="%22Urina-Triana+M%22">Urina-Triana M</searchLink>; Faculty of Health Sciences, Universidad Simón Bolívar, Barranquilla, Colombia.<br /><searchLink fieldCode="AU" term="%22Pietilä+M%22">Pietilä M</searchLink>; Heart Center, Turku University Hospital, University of Turku, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Lincoff+AM%22">Lincoff AM</searchLink>; Department of Cardiovascular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22SELECT+Trial+Investigators%22">SELECT Trial Investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2024 Aug 24; Vol. 404 (10454), pp. 773-786. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39181597 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(24)01498-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 773 Titles: – TitleFull: Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Deanfield J – PersonEntity: Name: NameFull: Verma S – PersonEntity: Name: NameFull: Scirica BM – PersonEntity: Name: NameFull: Kahn SE – PersonEntity: Name: NameFull: Emerson SS – PersonEntity: Name: NameFull: Ryan D – PersonEntity: Name: NameFull: Lingvay I – PersonEntity: Name: NameFull: Colhoun HM – PersonEntity: Name: NameFull: Plutzky J – PersonEntity: Name: NameFull: Kosiborod MN – PersonEntity: Name: NameFull: Hovingh GK – PersonEntity: Name: NameFull: Hardt-Lindberg S – PersonEntity: Name: NameFull: Frenkel O – PersonEntity: Name: NameFull: Weeke PE – PersonEntity: Name: NameFull: Rasmussen S – PersonEntity: Name: NameFull: Goudev A – PersonEntity: Name: NameFull: Lang CC – PersonEntity: Name: NameFull: Urina-Triana M – PersonEntity: Name: NameFull: Pietilä M – PersonEntity: Name: NameFull: Lincoff AM IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 08 Text: 2024 Aug 24 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1474-547X Numbering: – Type: volume Value: 404 – Type: issue Value: 10454 Titles: – TitleFull: Lancet (London, England) Type: main |
| ResultId | 1 |